Eliyahu Sharon Kalif - 03 Mar 2026 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role: EVP, Chief Financial Officer
Signature: /s/ Dov Bergwerk as attorney-in-fact for Eliyahu Sharon Kalif
Issuer symbol: TEVA
Transactions as of: 03 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 05 Mar 2026, 16:03:19 UTC
Previous filing: 02 Mar 2026
Next filing: 06 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Kalif Eliyahu Sharon	EVP, Chief Financial Officer	C/O TEVA PHARMACEUTICAL INDUSTRIES LTD., 124 DVORA HANEVI'A ST.,, TEL AVIV, ISRAEL	/s/ Dov Bergwerk as attorney-in-fact for Eliyahu Sharon Kalif	05 Mar 2026	0001798443

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TEVA	Ordinary Shares	Options Exercise		+49,800	+87%		107,278	03 Mar 2026	Direct	F1, F2
transaction	TEVA	Ordinary Shares	Options Exercise		+141,478	+132%		248,756	03 Mar 2026	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TEVA	Restricted Share Units	Options Exercise		-49,800	-50%	$0.000000^*	49,802	03 Mar 2026	Ordinary Shares	49,800		Direct	F1, F2, F3
transaction	TEVA	Restricted Share Units	Options Exercise		-141,478	-100%	$0.000000^*	0	03 Mar 2026	Ordinary Shares	141,478		Direct	F1, F2, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2	Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F3	Restricted share units were granted on March 3, 2023, with 49,800 vested on each of March 3, 2024, March 3, 2025 and March 4, 2026, and 49,802 vesting on March 3, 2027.
F4	Restricted share units were earned on January 27, 2026, as a result of the satisfaction of certain performance criteria certified by the Human Resources and Compensation Committee and subsequently vested on March 3, 2026, following satisfaction of the time-based vesting criteria.